KLRS
KLRS
NASDAQ · Biotechnology

Kalaris Therapeutics Inc

$2.85
-0.08 (-2.57%)
As of Sep 28, 10:20 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +704.6% upside
Low Target $19.41
Average Target $22.89
High Target $38.59
Current Price $2.85
Current
$2.85
Target
$22.89
$19.41 $22.89 avg $38.59
Scenario Analysis
Bear Case
$19.41
582.2%
Low target
Base Case
$22.89
+704.6%
Avg target
Bull Case
$38.59
+1,256.4%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$11.88
-76.1% from high
52-Week Low
$3.02
+-5.8% from low
Target vs 52W High
$22.89
+92.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%